Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets

被引：13

作者：

Alipoor, B. ^{[1
]}

Nikouei, S. ^{[2
]}

Rezaeinejad, F. ^{[3
]}

Malakooti-Dehkordi, S-N. ^{[4
]}

Sabati, Z. ^{[5
]}

Ghasemi, H. ^{[4
]}

机构：

[1] Yasuj Univ Med Sci, Fac Paramed, Dept Lab Sci, Yasuj, Iran

[2] Yasuj Univ Med Sci, Student Res Comm, Yasuj, Iran

[3] Yasuj Univ Med Sci, Fac Med, Dept Biochem, Yasuj, Iran

[4] Abadan Fac Med Sci, Abadan, Iran

[5] Iran Univ Med Sci, Sch Allied Med Sci, Student Res Comm, Hematol, Tehran, Iran

来源：

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 2021年 / 44卷 / 10期

关键词：

LncRNAs; Metabolic disorders; Diabetes; Biomarker; FATTY LIVER-DISEASE; HEPATIC STELLATE CELLS; COMPETING ENDOGENOUS RNA; HEDGEHOG SIGNALING PATHWAY; CORONARY-ARTERY-DISEASE; DOWN-REGULATION; DIABETES-MELLITUS; LIPID-METABOLISM; ADIPOSE-TISSUE; TRANSCRIPTOME ANALYSIS;

D O I：

10.1007/s40618-021-01559-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background It has been suggested that dysregulation of long non-coding RNAs (lncRNAs) could be associated with the incidence and development of metabolic disorders. Aim Accordingly, this narrative review described the molecular mechanisms of lncRNAs in the development of metabolic diseases including insulin resistance, diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), cirrhosis, and coronary artery diseases (CAD). Furthermore, we investigated the up-to-date findings on the association of deregulated lncRNAs in the metabolic disorders, and potential use of lncRNAs as biomarkers and therapeutic targets. Conclusion LncRNAs/miRNA/regulatory proteins axis plays a crucial role in progression of metabolic disorders and may be used in development of therapeutic and diagnostic approaches.

引用

页码：2015 / 2041

页数：27

共 50 条

[1] Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets
B. Alipoor
S. Nikouei
F. Rezaeinejad
S-N. Malakooti-Dehkordi
Z. Sabati
H. Ghasemi
Journal of Endocrinological Investigation, 2021, 44 : 2015 - 2041
[2] Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas
Sun, Yuanzhao
Wang, Zhong
Zhou, Dai
MEDICAL HYPOTHESES, 2013, 81 (02) : 319 - 321
[3] Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis
Wang, Chuqiao
Liang, Guorui
Shen, Jieni
Kong, Haifan
Wu, Donghong
Huang, Jinxiang
Li, Xuefeng
FRONTIERS IN IMMUNOLOGY, 2021, 12
[4] Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets
Gupta, Subash Chandra
Tripathi, Yashoda Nandan
INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (09) : 1955 - 1967
[5] Long non-coding RNAs: Potential therapeutic targets for epilepsy
Liu, Sen
Fan, Min
Ma, Meng-Die
Ge, Jin-Fang
Chen, Fei-Hu
FRONTIERS IN NEUROSCIENCE, 2022, 16
[6] MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma
Turai, Peter Istvan
Nyiro, Gabor
Butz, Henriett
Patocs, Attila
Igaz, Peter
CANCERS, 2021, 13 (07)
[7] Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets
Vercouillie, Niels
Ren, Zhiyao
Terras, Eva
Lammens, Tim
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
[8] Long non-coding RNAs as biomarkers and therapeutic targets for ischemic stroke
Sufianova, Galina
Shumadalova, Alina
Yao, Wenhao
Gareev, Ilgiz
NON-CODING RNA RESEARCH, 2022, 7 (04): : 226 - 232
[9] Long non-coding RNAs and their targets as potential biomarkers in breast cancer
Khalid, Maryam
Paracha, Rehan Zafar
Nisar, Maryum
Malik, Sumaira
Tariq, Salma
Arshad, Iqra
Siddiqa, Amnah
Hussain, Zamir
Ahmad, Jamil
Ali, Amjad
IET SYSTEMS BIOLOGY, 2021, 15 (05) : 137 - 147
[10] Long non-coding RNAs in immune regulation and their potential as therapeutic targets
Kumar, Dinesh Babu Uthaya
Williams, Adam
INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 81

← 1 2 3 4 5 →